Q4 2023 Holdings
Filed 2024-02-13 | 48 holdings | $944.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $105.4M | 800,000 | 11.2% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $89.2M | 725,000 | 9.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $78.7M | 625,000 | 8.3% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $58.1M | 1,530,000 | 6.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $52.3M | 1,300,000 | 5.5% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $43.6M | 400,000 | 4.6% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $42.6M | 800,000 | 4.5% |
| Pacira BioSciences Inc(PCRX) | COM | 695127100 | $40.5M | 1,200,000 | 4.3% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $38.4M | 1,625,000 | 4.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $33.0M | 525,000 | 3.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $27.9M | 900,000 | 3.0% |
| uniQure NV(QURE) | SHS | N90064101 | $26.6M | 3,925,000 | 2.8% |
| ALX Oncology Holdings Inc(ALXO) | COM | 00166B105 | $24.6M | 1,655,000 | 2.6% |
| Immatics NV(IMTX) | SHS | N44445109 | $22.1M | 2,100,000 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $21.8M | 1,000,000 | 2.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $20.8M | 725,000 | 2.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $19.4M | 75,000 | 2.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $17.2M | 225,000 | 1.8% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $16.8M | 250,000 | 1.8% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $16.0M | 450,000 | 1.7% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $15.7M | 3,000,000 | 1.7% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $14.9M | 300,000 | 1.6% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $14.7M | 200,000 | 1.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $13.9M | 4,155,000 | 1.5% |
| Liquidia Corp(LQDA) | COM NEW | 53635D202 | $12.3M | 1,025,000 | 1.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $9.1M | 400,000 | 1.0% |
| Regeneron Pharmaceuticals Inc(REGN) | COM | 75886F107 | $8.8M | 10,000 | 0.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $8.7M | 2,700,000 | 0.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.1M | 175,000 | 0.9% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $6.9M | 1,025,000 | 0.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.7M | 35,000 | 0.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.3M | 130,000 | 0.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $4.8M | 1,290,000 | 0.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.2M | 50,000 | 0.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $3.3M | 60,000 | 0.4% |
| Bluebird Bio Inc | COM | 09609G100 | $3.0M | 2,150,000 | 0.3% |
| Teva Pharmaceutical Industries(TEVA) | SPONSORED ADS | 881624209 | $2.1M | 200,000 | 0.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $1.4M | 135,000 | 0.1% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $1.3M | 1,400,000 | 0.1% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $792.0K | 440,000 | 0.1% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $640.0K | 400,000 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $635.7K | 322,671 | 0.1% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $476.1K | 115,000 | 0.1% |
| Affimed NV | COM | N01045108 | $341.3K | 546,067 | 0.0% |
| Ovid therapeutics Inc(OVID) | COM | 690469101 | $275.1K | 85,429 | 0.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $209.3K | 34,085 | 0.0% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $179.9K | 20,306 | 0.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $96.1K | 108,083 | 0.0% |